MedinCell launches a Global Offering for approximately 25 million euros
May 11, 2023
Previous PostMedinCell announces the successful pricing of its Global Offering and raises €25 million
Next PostMedinCell: mdc-TJK's (Teva's codename: TEV-44749) Phase 1 study pharmacokinetics to be presented for the first time by Teva at SIRS 2023 (May 11-15, 2023, Toronto, Canada)
